Armistice Capital, LLC and Steven Boyd report beneficial ownership of 167,513 Ordinary Shares of Wearable Devices Ltd., representing 4.99% of the class. These shares are held by Armistice Capital Master Fund Ltd., for which Armistice Capital is investment manager and exercises voting and investment power under an Investment Management Agreement.
Armistice Capital and Steven Boyd may be deemed to share voting and dispositive power over all 167,513 shares, while the Master Fund has the right to receive dividends and sale proceeds. The filing confirms ownership of 5 percent or less of the issuer’s outstanding Ordinary Shares.
Wearable Devices Ltd. disclosed that J.B.D Innovation Ltd., Nissim Daniel, Victor Tshuva & Co. – Law Offices, and Victor Tshuva have sold all of their Ordinary Shares and no longer beneficially own any stake in the company. As of August 11, 2026, each reporting person holds 0 Ordinary Shares, representing 0% of the outstanding class, with no voting or dispositive power and no pecuniary interest.
On August 10, 2026, the group sold an aggregate 258,126 Ordinary Shares in open-market transactions, and on August 11, 2026, a further 123,235 shares, fully exiting their position and ceasing to be beneficial owners of 5% or more of the company’s Ordinary Shares.
Wearable Devices Ltd. and reporting holders J.B.D Innovation Ltd., Nissim Daniel, Victor Tshuva & Co. – Law Offices, and Victor Tshuva amended their Schedule 13D to reflect a new cooperation arrangement and updated ownership. The group has shared voting power over 381,361 ordinary shares, representing 15.50% of Wearable Devices’ outstanding 2,459,741 ordinary shares.
Under an August 7, 2026 Cooperation Agreement, two existing directors will resign and four new directors will be appointed, resulting in a seven‑member board. The parties’ court proceedings relating to a previously announced private placement were dismissed on August 10, 2026 with no order as to costs, and the demand for a special shareholder meeting was withdrawn. For two years, the reporting persons and their affiliates agreed not to seek to change or influence the company’s governance or management beyond what the agreement permits.
In a related Side Letter, J.B.D Innovation Ltd. committed, for 24 months, to provide the company with not less than $12.0 million in convertible debt financing if the board determines the company lacks sufficient resources to fund operations for the following 24 months.
Wearable Devices Ltd., an AI-powered touchless sensing wearables company, reports that the U.S. Patent and Trademark Office has granted a new continuation patent in its foundational “Gesture and Voice-Controlled Interface Device” family. The patent covers technologies that authenticate users based on combined gesture data and unique biological signals.
The granted claims describe a gesture interface device that integrates gesture sensors with biopotential sensors to record neural signals, then uses a processor to analyze gestures against a personalized gesture signature and build a gesture metric space. This supports accurate user verification and may enable use cases such as secure payments, user detection, and authorization of sensitive actions, enhancing the company’s hybrid voice-and-gesture control platform and broader neural input IP strategy.
Wearable Devices Ltd. reported closing a previously announced private placement with a single institutional investor, raising aggregate gross proceeds of approximately $3.3 million before fees. The transaction followed dismissal, on August 10, 2026, of court proceedings that had temporarily halted the financing.
The company entered into a Cooperation Agreement with shareholder groups J.B.D Innovation Ltd. and Victor Tshuva & Co., resolving a governance dispute and related court actions. On the effective date, two directors will resign and four new independent directors will join, bringing the board to seven members. The shareholders agreed to withdraw their demand letter, terminate litigation, provide mutual releases and observe a two‑year standstill on efforts to change governance outside agreed channels.
In a related side letter, J.B.D committed that, if the board later determines the company lacks resources to fund at least 24 months of operations, it will provide at least $12.0 million in convertible debt financing over a 24‑month period, with detailed terms to be negotiated in good faith.
Wearable Devices Ltd. agreed on July 31, 2026 to a private placement with a single institutional investor for 240,000 ordinary shares at $3.285 per share and pre-funded warrants for up to 760,000 ordinary shares at $3.2849, together with ordinary warrants to purchase up to 1,000,000 ordinary shares at an exercise price of $3.16, for expected gross proceeds of approximately $3.3 million. The securities are unregistered and rely on Section 4(a)(2) and/or Regulation D, with a resale registration statement to be filed within 30 days and pursued to effectiveness.
The company plans to use net proceeds for commercialization of its Mudra products, development and manufacturing of next-generation product lines, advancement of its AI6 Labs initiatives, potential strategic transactions, and working capital and other general corporate purposes. A.G.P./Alliance Global Partners is exclusive placement agent, entitled to a 7% cash fee, a 1% management fee and expense reimbursement up to $50,000. The agreements impose near-term restrictions on new equity issuances, variable-rate transactions for six months, and 30‑day lock-ups for directors and executive officers.
An interim ex parte order from the Economic Department of the Haifa District Court temporarily prohibits advancing the offering and making any change to the company’s capital structure. A hearing is scheduled for August 12, 2026, and the transaction cannot be completed while the order remains in effect, with no assurance as to outcome or timing.
Wearable Devices Ltd. reports that shareholders J.B.D Innovation Ltd. and Victor Tshuva & Co. – Law Offices have initiated legal proceedings in the Economic Department of the Haifa District Court relating to its recently announced private placement of 1,000,000 ordinary shares and warrants to purchase up to 1,000,000 ordinary shares with a single institutional investor.
On August 2, 2026, the Court issued an interim ex parte order temporarily prohibiting the company from advancing the private placement or effecting any change in its capital structure, pending a hearing now set for August 12, 2026. The plaintiffs must post security including a third‑party guarantee and NIS 250,000 in additional security. Wearable Devices has filed a response seeking denial of the motion and intends to defend itself vigorously. The company states it cannot complete the private placement while the order remains in effect and gives no assurance regarding the timing or outcome of the proceedings.
J.B.D Innovation Ltd., Nissim Daniel, Victor Tshuva & Co. - Law Offices, and Victor Tshuva report beneficial ownership of 381,361 Ordinary Shares of Wearable Devices Ltd., representing 17.42% of the outstanding class of 2,189,469 Ordinary Shares as of June 17, 2026.
The reporting persons describe their objection to Wearable Devices’ agreement with a single institutional investor for a private placement of 1,000,000 Ordinary Shares (or equivalents) and warrants to purchase up to 1,000,000 Ordinary Shares at a combined price of $3.285 per share and accompanying warrant. They have initiated proceedings in the Economic Department of the District Court of Haifa seeking temporary injunctive relief, and on August 2, 2026 the court issued an ex parte temporary injunction that temporarily prohibits advancing the private placement or otherwise modifying the capital structure pending a hearing scheduled for August 16, 2026; the decision is described as preliminary and not a determination of the outcome. The reporting persons state that they intend to continue pursuing their rights and remedies.
An amended Schedule 13D for Wearable Devices Ltd. reports that reporting persons led by J.B.D Innovation Ltd. and Victor Tshuva & Co. – Law Offices sold an aggregate 162,000 Ordinary Shares on July 27, 2026 in open market transactions.
After these sales, the group reports beneficial ownership of 381,361 Ordinary Shares, representing 17.42% of Wearable Devices’ outstanding share capital, based on 2,189,469 shares outstanding as of June 17, 2026. J.B.D holds sole dispositive power over 315,361 shares (about 14.40%), while Victor Tshuva & Co. holds sole dispositive power over 66,000 shares (about 3.01%). The July 27, 2026 sale was executed at a weighted average price of approximately $3.812 per share, for aggregate gross proceeds of about $617,544 before costs.
Wearable Devices Ltd. reports that on July 27, 2026, shareholders J.B.D Innovation Ltd. and Victor Tshuva & Co. – Law Offices, holding approximately 24.8% of its voting rights, demanded that the board convene a special general meeting under Israeli law. Their proposals include amending provisions governing director elections and removals, removing four of the company’s five current directors, electing four nominees they designate, and asking the company to refrain from certain non‑ordinary‑course financing and strategic actions until the meeting.
The board is reviewing this demand with legal advisors and indicates there is no assurance regarding the outcome or timing. Wearable Devices also updates its risk disclosures to highlight that shareholder activism, including this campaign, proxy contests, related litigation, and any resulting changes in board composition or strategy could materially and adversely affect its business, financial condition, results of operations and the market price of its ordinary shares.